This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Comment on: ‘Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients’ Radiother Oncol 70: 261–264, 2004 by Dr Rades et al., Radiotherapy and Oncology, October 2004, Elsevier,
DOI: 10.1016/j.radonc.2004.07.027.
You can read the full text:
Be the first to contribute to this page
